Related Experiment Video
Updated: Jun 28, 2026

09:01
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
Novel factor-loaded polyphosphazene matrices: potential for driving angiogenesis
Olugbemisola Oredein-McCoy1, Nicholas R Krogman, Arlin L Weikel
1Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Journal of Microencapsulation
|October 31, 2008
Summary
This study developed novel polyphosphazene (Pphos) scaffolds for enhanced bone tissue engineering. The new method effectively incorporates proteins, showing potential for controlled release of angiogenic factors to promote vascularization.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Drug Delivery
Background:
- Current bone tissue engineered scaffolds often lack vascularization capabilities.
- Angiogenic factors are crucial for enhancing scaffold vascularization.
- Polyphosphazenes (Pphos) offer a promising platform for controlled release applications.
Purpose of the Study:
- To fabricate and characterize protein-loaded Pphos-based scaffolds using a novel sintering method.
- To evaluate the efficacy of a solvent-non-solvent technique for protein incorporation.
- To assess the potential for developing angiogenic factor-loaded Pphos matrices for neovascularization.
Main Methods:
- Fabrication of Pphos and Pphos-hydroxyapatite (HAp) composite microspheres via emulsion solvent evaporation.
- Protein loading using a novel solvent-non-solvent approach with bovine serum albumin (BSA).
- Characterization of scaffold morphology, porosity, protein structure, distribution, and release kinetics.
Main Results:
- Porous microsphere scaffolds exhibited sufficient sintering and porosity within the trabecular bone range.
- The solvent sintering method preserved the secondary protein structure of BSA.
- BSA demonstrated a steady, zero-order release profile over 21 days, with HAp improving the pattern.
Conclusions:
- The novel solvent-non-solvent technique is optimal for protein loading into Pphos scaffolds.
- HAp incorporation enhances the release profile, indicating potential for growth factor delivery.
- These Pphos scaffolds show promise for developing angiogenic factor-loaded matrices to induce neovascularization.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Overview of Cell-Matrix Interactions
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...

